Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
Global phosphorylation analysis of β-arrestin–mediated signaling downstream of a seven transmembrane receptor (7TMR)
2010 StandoutNobel
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Arresting a Transient Receptor Potential (TRP) Channel
2010 StandoutNobel
β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
2009 StandoutNobel
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
2005 StandoutNobel
Cancer statistics, 2020
2020 Standout
Molecular Cloning and Characterization of an Aquaporin cDNA from Salivary, Lacrimal, and Respiratory Tissues
1995 StandoutNobel
The Active Conformation of β-Arrestin1
2007 StandoutNobel
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
1989
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
A view on drug resistance in cancer
2019 StandoutNature
Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor
2004 StandoutNobel
Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation
2006 StandoutNobel
Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance
2004 StandoutNobel
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
2007 StandoutNobel
Neuropsychiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or Macrocytosis
1988 Standout
μ and δ Opioid Receptors Are Differentially Desensitized by the Coexpression of β-Adrenergic Receptor Kinase 2 and β-Arrestin 2 in Xenopus Oocytes
1997
Cancer drug resistance: an evolving paradigm
2013 Standout
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tolerance to μ‐opioid agonists in human neuroblastoma SH‐SY5Y cells as determined by changes in guanosine‐5′‐O‐(3‐[35S]‐thio)triphosphate binding
1997
Ubiquitination of β-Arrestin Links Seven-transmembrane Receptor Endocytosis and ERK Activation
2007 StandoutNobel
Agonist-dependent Desensitization of the κ Opioid Receptor by G Protein Receptor Kinase and β-Arrestin
1999
Chemotherapy and the war on cancer
2005 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
2015
Cardiac-specific overexpression of AT1 receptor mutant lacking G q/G i coupling causes hypertrophy and bradycardia in transgenic mice
2005
β-Arrestin 2-Dependent Angiotensin II Type 1A Receptor-Mediated Pathway of Chemotaxis
2005 StandoutNobel
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Reciprocal Regulation of Angiotensin Receptor-activated Extracellular Signal-regulated Kinases by β-Arrestins 1 and 2
2004 StandoutNobel
Head and Neck Cancer
1993 Standout
Mcl‐1 and Bcl‐2/Bax ratio are associated with treatment response but not with Rai stage in B‐cell chronic lymphocytic leukemia
2003
Requirements for high impact diagnostics in the developing world
2006 StandoutNature
Pyrimidine pathways in health and disease
2005
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Mitoxantrone
1996
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Defects in the Ubiquitin Pathway Induce Caspase-independent Apoptosis Blocked by Bcl-2
1998 StandoutNobel
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
MCL-1 Promoter Insertions Dial-Up Aggressiveness of Chronic Leukemia
2004
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
White matter ultrastructural pathology of experimental Creutzfeldt-Jakob disease in mice
1989 Nobel
Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia
2012
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
2008 StandoutNobel
Impaired assimilation of egg Co 57 vitamin B 12 in patients with hypochlorhydria and achlorhydria and after gastric resection.
1973
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins
2003
Regional mapping of prion proteins in brain.
1992 StandoutNobel
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
2005 Standout
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
2003 StandoutNobel
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia
2004
Practice Guidelines for the Management of Infectious Diarrhea
2001
Radiotherapy with Concomitant Chemotherapy for Head and Neck Cancer
1991
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
2000 StandoutNatureNobel
β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
2006 StandoutNobel
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
2009 StandoutNobel
Impaired Assimilation of EGG CO57 Vitamin B12 in Patients With Hypochlorhydria and Achlorhydria and After Gastric Resection
1973
Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity
2000 StandoutNobel
Toward the potential cure of leukemias in the next decade
2018
Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor
2005 StandoutNobel
Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1
2002
A millennium update on pediatric diarrheal illness in the developing world
2005
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia
2001
Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor.
1993
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
2009 StandoutNobel
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
2006 StandoutScience
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Transduction of Receptor Signals by ß-Arrestins
2005 StandoutScienceNobel
Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness
1998
Organically modified silica nanoparticles: A nonviral vector for in vivo gene delivery and expression in the brain
2005
Works of John Hines being referenced
Chemoradiotherapy as initial management in patients with squamous cell carcinoma of the head and neck.
1986
Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways
2003
Long-Term Results After Chemoradiotherapy for Locally Confined Squamous-Cell Head and Neck Cancer
1990
Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer
1990
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
2000
Mitoxantrone and Etoposide in Patients with Relapsed and Refractory Acute Nonlymphocytic Leukemia
1990
Effective Use of the Clinical Microbiology Laboratory for Diagnosing Diarrheal Diseases
1996
Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.
1988
Mixed Small Cell and Non-Small Cell Lung Cancer
1986
Cerebellar degeneration caused by high‐dose cytosine arabinoside: A clinicopathological study
1983
Expression of Apoptosis-Regulating Proteins in Chronic Lymphocytic Leukemia: Correlations With In Vitro and In Vivo Chemoresponses
1998
Novel Nuclear Signaling Pathway Mediates Activation of Fibroblast Growth Factor-2 Gene by Type 1 and Type 2 Angiotensin II Receptors
2001
Neuropathology of experimental vitamin B 12 deficiency in monkeys
1976
Fluorouracil Modulation in Colorectal Cancer: Lack of Improvement With N -Phosphonoacetyl- l -Aspartic Acid or Oral Leucovorin or Interferon, But Enhanced Therapeutic Index With Weekly 24-Hour Infusion Schedule—An Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study
2001
Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
1994
Molecular Biology of Opioid Receptors
1996
Megaloblastic Anemia in an Adult Vegan
1966
Energy‐dispersive X‐ray Analysis of the Mitochondria of Sideroblastic Anaemia
1980
The hematologic complications following partial gastrectomy
1967
An Ultrastructural Study of Subacute Combined Degeneration of the Spinal Cord in Vitamin B12-Deficient Rhesus Monkeys
1978